Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.

Using spectroscopic, calorimetric and microscopic methods, we demonstrate that calcium binds to beta-2-microglobulin (β2m) under physiological conditions of pH and ionic strength, in biological buffers, causing a conformational change associated with the binding of up to four calcium atoms per β2m m...

Full description

Bibliographic Details
Main Authors: Sukhdeep Kumar, Prerna Sharma, Kanika Arora, Manoj Raje, Purnananda Guptasarma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3995793?pdf=render
id doaj-0e423452380a4c928b4640c49c860a3e
record_format Article
spelling doaj-0e423452380a4c928b4640c49c860a3e2020-11-25T02:11:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0194e9572510.1371/journal.pone.0095725Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.Sukhdeep KumarPrerna SharmaKanika AroraManoj RajePurnananda GuptasarmaUsing spectroscopic, calorimetric and microscopic methods, we demonstrate that calcium binds to beta-2-microglobulin (β2m) under physiological conditions of pH and ionic strength, in biological buffers, causing a conformational change associated with the binding of up to four calcium atoms per β2m molecule, with a marked transformation of some random coil structure into beta sheet structure, and culminating in the aggregation of the protein at physiological (serum) concentrations of calcium and β2m. We draw attention to the fact that the sequence of β2m contains several potential calcium-binding motifs of the DXD and DXDXD (or DXEXD) varieties. We establish (a) that the microscopic aggregation seen at physiological concentrations of β2m and calcium turns into actual turbidity and visible precipitation at higher concentrations of protein and β2m, (b) that this initial aggregation/precipitation leads to the formation of amorphous aggregates, (c) that the formation of the amorphous aggregates can be partially reversed through the addition of the divalent ion chelating agent, EDTA, and (d) that upon incubation for a few weeks, the amorphous aggregates appear to support the formation of amyloid aggregates that bind to the dye, thioflavin T (ThT), resulting in increase in the dye's fluorescence. We speculate that β2m exists in the form of microscopic aggregates in vivo and that these don't progress to form larger amyloid aggregates because protein concentrations remain low under normal conditions of kidney function and β2m degradation. However, when kidney function is compromised and especially when dialysis is performed, β2m concentrations probably transiently rise to yield large aggregates that deposit in bone joints and transform into amyloids during dialysis related amyloidosis.http://europepmc.org/articles/PMC3995793?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Sukhdeep Kumar
Prerna Sharma
Kanika Arora
Manoj Raje
Purnananda Guptasarma
spellingShingle Sukhdeep Kumar
Prerna Sharma
Kanika Arora
Manoj Raje
Purnananda Guptasarma
Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
PLoS ONE
author_facet Sukhdeep Kumar
Prerna Sharma
Kanika Arora
Manoj Raje
Purnananda Guptasarma
author_sort Sukhdeep Kumar
title Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
title_short Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
title_full Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
title_fullStr Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
title_full_unstemmed Calcium binding to beta-2-microglobulin at physiological pH drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
title_sort calcium binding to beta-2-microglobulin at physiological ph drives the occurrence of conformational changes which cause the protein to precipitate into amorphous forms that subsequently transform into amyloid aggregates.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Using spectroscopic, calorimetric and microscopic methods, we demonstrate that calcium binds to beta-2-microglobulin (β2m) under physiological conditions of pH and ionic strength, in biological buffers, causing a conformational change associated with the binding of up to four calcium atoms per β2m molecule, with a marked transformation of some random coil structure into beta sheet structure, and culminating in the aggregation of the protein at physiological (serum) concentrations of calcium and β2m. We draw attention to the fact that the sequence of β2m contains several potential calcium-binding motifs of the DXD and DXDXD (or DXEXD) varieties. We establish (a) that the microscopic aggregation seen at physiological concentrations of β2m and calcium turns into actual turbidity and visible precipitation at higher concentrations of protein and β2m, (b) that this initial aggregation/precipitation leads to the formation of amorphous aggregates, (c) that the formation of the amorphous aggregates can be partially reversed through the addition of the divalent ion chelating agent, EDTA, and (d) that upon incubation for a few weeks, the amorphous aggregates appear to support the formation of amyloid aggregates that bind to the dye, thioflavin T (ThT), resulting in increase in the dye's fluorescence. We speculate that β2m exists in the form of microscopic aggregates in vivo and that these don't progress to form larger amyloid aggregates because protein concentrations remain low under normal conditions of kidney function and β2m degradation. However, when kidney function is compromised and especially when dialysis is performed, β2m concentrations probably transiently rise to yield large aggregates that deposit in bone joints and transform into amyloids during dialysis related amyloidosis.
url http://europepmc.org/articles/PMC3995793?pdf=render
work_keys_str_mv AT sukhdeepkumar calciumbindingtobeta2microglobulinatphysiologicalphdrivestheoccurrenceofconformationalchangeswhichcausetheproteintoprecipitateintoamorphousformsthatsubsequentlytransformintoamyloidaggregates
AT prernasharma calciumbindingtobeta2microglobulinatphysiologicalphdrivestheoccurrenceofconformationalchangeswhichcausetheproteintoprecipitateintoamorphousformsthatsubsequentlytransformintoamyloidaggregates
AT kanikaarora calciumbindingtobeta2microglobulinatphysiologicalphdrivestheoccurrenceofconformationalchangeswhichcausetheproteintoprecipitateintoamorphousformsthatsubsequentlytransformintoamyloidaggregates
AT manojraje calciumbindingtobeta2microglobulinatphysiologicalphdrivestheoccurrenceofconformationalchangeswhichcausetheproteintoprecipitateintoamorphousformsthatsubsequentlytransformintoamyloidaggregates
AT purnanandaguptasarma calciumbindingtobeta2microglobulinatphysiologicalphdrivestheoccurrenceofconformationalchangeswhichcausetheproteintoprecipitateintoamorphousformsthatsubsequentlytransformintoamyloidaggregates
_version_ 1724911637066940416